PubMed

Novel cancer vaccine based on genes of Salmonella pathogenicity Island 2.

Xiong G, Husseiny MI, Song L, Erdreich-Epstein A, Shackleford GM, Seeger RC, Jäckel D, Hensel M, Metelitsa LS.

Int J Cancer. 2009 Oct 12. [Epub ahead of print]PMID: 19824039 [PubMed - as supplied by publisher]Related articles

Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.

Okamatsu C, London WB, Naranjo A, Hogarty MD, Gastier-Foster JM, Look AT, LaQuaglia M, Maris JM, Cohn SL, Matthay KK, Seeger RC, Saji T, Shimada H.

Pediatr Blood Cancer. 2009 Oct;53(4):563-9.PMID: 19530234 [PubMed - indexed for MEDLINE]Related articles

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.

Capasso M, Devoto M, Hou C, Asgharzadeh S, Glessner JT, Attiyeh EF, Mosse YP, Kim C, Diskin SJ, Cole KA, Bosse K, Diamond M, Laudenslager M, Winter C, Bradfield JP, Scott RH, Jagannathan J, Garris M, McConville C, London WB, Seeger RC, Grant SF, Li H, Rahman N, Rappaport E, Hakonarson H, Maris JM.

Nat Genet. 2009 Jun;41(6):718-723. Epub 2009 May 3.PMID: 19412175 [PubMed - as supplied by publisher]Related articles

Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages.

Song L, Asgharzadeh S, Salo J, Engell K, Wu HW, Sposto R, Ara T, Silverman AM, DeClerck YA, Seeger RC, Metelitsa LS.

J Clin Invest. 2009 Jun;119(6):1524-36.PMID: 19411762 [PubMed - indexed for MEDLINE]Related articlesFree article

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.

Beiske K, Burchill SA, Cheung IY, Hiyama E, Seeger RC, Cohn SL, Pearson AD, Matthay KK; International neuroblastoma Risk Group Task Force.

Br J Cancer. 2009 May 19;100(10):1627-37. Epub 2009 Apr 28.PMID: 19401690 [PubMed - indexed for MEDLINE]Related articles

ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome.

Huang S, Laoukili J, Epping MT, Koster J, Hölzel M, Westerman BA, Nijkamp W, Hata A, Asgharzadeh S, Seeger RC, Versteeg R, Beijersbergen RL, Bernards R.

Cancer Cell. 2009 Apr 7;15(4):328-40.PMID: 19345331 [PubMed - indexed for MEDLINE]Related articles

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.

Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, Gerbing RB, London WB, Villablanca JG.

J Clin Oncol. 2009 Mar 1;27(7):1007-13. Epub 2009 Jan 26.PMID: 19171716 [PubMed - indexed for MEDLINE]Related articles

Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells.

Ara T, Song L, Shimada H, Keshelava N, Russell HV, Metelitsa LS, Groshen SG, Seeger RC, DeClerck YA.

Cancer Res. 2009 Jan 1;69(1):329-37.PMID: 19118018 [PubMed - indexed for MEDLINE]Related articlesFree article

Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.

Park JR, Villablanca JG, London WB, Gerbing RB, Haas-Kogan D, Adkins ES, Attiyeh EF, Maris JM, Seeger RC, Reynolds CP, Matthay KK; Children's Oncology Group.

Pediatr Blood Cancer. 2009 Jan;52(1):44-50.PMID: 18937318 [PubMed - indexed for MEDLINE]Related articlesFree article

Molecular characterization of the pediatric preclinical testing panel.

Neale G, Su X, Morton CL, Phelps D, Gorlick R, Lock RB, Reynolds CP, Maris JM, Friedman HS, Dome J, Khoury J, Triche TJ, Seeger RC, Gilbertson R, Khan J, Smith MA, Houghton PJ.

Clin Cancer Res. 2008 Jul 15;14(14):4572-83.PMID: 18628472 [PubMed - indexed for MEDLINE]Related articlesFree article

An integrated cross-platform prognosis study on neuroblastoma patients.

Chen QR, Song YK, Wei JS, Bilke S, Asgharzadeh S, Seeger RC, Khan J.

Genomics. 2008 Oct;92(4):195-203. Epub 2008 Jul 30.PMID: 18598751 [PubMed - indexed for MEDLINE]Related articlesFree article

Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.

Maris JM, Mosse YP, Bradfield JP, Hou C, Monni S, Scott RH, Asgharzadeh S, Attiyeh EF, Diskin SJ, Laudenslager M, Winter C, Cole KA, Glessner JT, Kim C, Frackelton EC, Casalunovo T, Eckert AW, Capasso M, Rappaport EF, McConville C, London WB, Seeger RC, Rahman N, Devoto M, Grant SF, Li H, Hakonarson H.

N Engl J Med. 2008 Jun 12;358(24):2585-93. Epub 2008 May 7.PMID: 18463370 [PubMed - indexed for MEDLINE]Related articlesFree article

Cdc6 knockdown inhibits human neuroblastoma cell proliferation.

Feng L, Barnhart JR, Seeger RC, Wu L, Keshelava N, Huang SH, Jong A.

Mol Cell Biochem. 2008 Apr;311(1-2):189-97. Epub 2008 Feb 8.PMID: 18259842 [PubMed - indexed for MEDLINE]Related articles

Sparse representation and Bayesian detection of genome copy number alterations from microarray data.

Pique-Regi R, Monso-Varona J, Ortega A, Seeger RC, Triche TJ, Asgharzadeh S.

Bioinformatics. 2008 Feb 1;24(3):309-18. Epub 2008 Jan 18.PMID: 18203770 [PubMed - indexed for MEDLINE]Related articlesFree article

De novo identification of MIZ-1 (ZBTB17) encoding a MYC-interacting zinc-finger protein as a new favorable neuroblastoma gene.

Ikegaki N, Gotoh T, Kung B, Riceberg JS, Kim DY, Zhao H, Rappaport EF, Hicks SL, Seeger RC, Tang XX.

Clin Cancer Res. 2007 Oct 15;13(20):6001-9.PMID: 17947461 [PubMed - indexed for MEDLINE]Related articlesFree article

Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma.

Song L, Ara T, Wu HW, Woo CW, Reynolds CP, Seeger RC, DeClerck YA, Thiele CJ, Sposto R, Metelitsa LS.

J Clin Invest. 2007 Sep;117(9):2702-12.PMID: 17710228 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification.

Asgharzadeh S, Pique-Regi R, Sposto R, Wang H, Yang Y, Shimada H, Matthay K, Buckley J, Ortega A, Seeger RC.

J Natl Cancer Inst. 2006 Sep 6;98(17):1193-203.PMID: 16954472 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group.

Osenga KL, Hank JA, Albertini MR, Gan J, Sternberg AG, Eickhoff J, Seeger RC, Matthay KK, Reynolds CP, Twist C, Krailo M, Adamson PC, Reisfeld RA, Gillies SD, Sondel PM; Children's Oncology Group.

Clin Cancer Res. 2006 Mar 15;12(6):1750-9.PMID: 16551859 [PubMed - indexed for MEDLINE]Related articlesFree article

The MYCN enigma: significance of MYCN expression in neuroblastoma.

Tang XX, Zhao H, Kung B, Kim DY, Hicks SL, Cohn SL, Cheung NK, Seeger RC, Evans AE, Ikegaki N.

Cancer Res. 2006 Mar 1;66(5):2826-33.PMID: 16510605 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.

Matthay KK, Tan JC, Villablanca JG, Yanik GA, Veatch J, Franc B, Twomey E, Horn B, Reynolds CP, Groshen S, Seeger RC, Maris JM.

J Clin Oncol. 2006 Jan 20;24(3):500-6.PMID: 16421427 [PubMed - indexed for MEDLINE]Related articles

Chromosome 1p and 11q deletions and outcome in neuroblastoma.

Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM; Children's Oncology Group.

N Engl J Med. 2005 Nov 24;353(21):2243-53.PMID: 16306521 [PubMed - indexed for MEDLINE]Related articlesFree article

Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.

Schmidt ML, Lal A, Seeger RC, Maris JM, Shimada H, O'Leary M, Gerbing RB, Matthay KK.

J Clin Oncol. 2005 Sep 20;23(27):6474-80. Epub 2005 Aug 22.PMID: 16116154 [PubMed - indexed for MEDLINE]Related articles

Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.

London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, Thorner P, Brodeur G, Maris JM, Reynolds CP, Cohn SL.

J Clin Oncol. 2005 Sep 20;23(27):6459-65. Epub 2005 Aug 22.PMID: 16116153 [PubMed - indexed for MEDLINE]Related articles

Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.

Kobayashi C, Monforte-Munoz HL, Gerbing RB, Stram DO, Matthay KK, Lukens JN, Seeger RC, Shimada H.

Cancer. 2005 Jan 1;103(1):174-80.PMID: 15549714 [PubMed - indexed for MEDLINE]Related articlesFree article

GABAergic system gene expression predicts clinical outcome in patients with neuroblastoma.

Roberts SS, Mori M, Pattee P, Lapidus J, Mathews R, O'Malley JP, Hsieh YC, Turner MA, Wang Z, Tian Q, Rodland MJ, Reynolds CP, Seeger RC, Nagalla SR.

J Clin Oncol. 2004 Oct 15;22(20):4127-34.PMID: 15483022 [PubMed - indexed for MEDLINE]Related articles

TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.

Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC.

Cancer. 2004 Oct 15;101(8):1873-81.PMID: 15386308 [PubMed - indexed for MEDLINE]Related articlesFree article

Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2.

Metelitsa LS, Wu HW, Wang H, Yang Y, Warsi Z, Asgharzadeh S, Groshen S, Wilson SB, Seeger RC.

J Exp Med. 2004 May 3;199(9):1213-21.PMID: 15123743 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells.

Metelitsa LS, Weinberg KI, Emanuel PD, Seeger RC.

Leukemia. 2003 Jun;17(6):1068-77.PMID: 12764370 [PubMed - indexed for MEDLINE]Related articles

Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study.

Haas-Kogan DA, Swift PS, Selch M, Haase GM, Seeger RC, Gerbing RB, Stram DO, Matthay KK.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):28-39.PMID: 12694821 [PubMed - indexed for MEDLINE]Related articles

Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis.

Metelitsa LS, Gillies SD, Super M, Shimada H, Reynolds CP, Seeger RC.

Blood. 2002 Jun 1;99(11):4166-73.PMID: 12010822 [PubMed - indexed for MEDLINE]Related articlesFree article

Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line.

Anderson CP, Seeger RC, Satake N, Monforte-Munoz HL, Keshelava N, Bailey HH, Reynolds CP.

J Pediatr Hematol Oncol. 2001 Nov;23(8):500-5.PMID: 11878777 [PubMed - indexed for MEDLINE]Related articles

Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

Goto S, Umehara S, Gerbing RB, Stram DO, Brodeur GM, Seeger RC, Lukens JN, Matthay KK, Shimada H.

Cancer. 2001 Nov 15;92(10):2699-708.PMID: 11745206 [PubMed - indexed for MEDLINE]Related articlesFree article

Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.

Metelitsa LS, Naidenko OV, Kant A, Wu HW, Loza MJ, Perussia B, Kronenberg M, Seeger RC.

J Immunol. 2001 Sep 15;167(6):3114-22.PMID: 11544296 [PubMed - indexed for MEDLINE]Related articlesFree article

Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow.

Hoon DS, Kuo CT, Wen S, Wang H, Metelitsa L, Reynolds CP, Seeger RC.

Am J Pathol. 2001 Aug;159(2):493-500.PMID: 11485908 [PubMed - indexed for MEDLINE]Related articlesFree article

Comprehensive analysis of chromosome 1p deletions in neuroblastoma.

Maris JM, Guo C, Blake D, White PS, Hogarty MD, Thompson PM, Rajalingam V, Gerbing R, Stram DO, Matthay KK, Seeger RC, Brodeur GM.

Med Pediatr Oncol. 2001 Jan;36(1):32-6.PMID: 11464900 [PubMed - indexed for MEDLINE]Related articles

Loss of heterozygosity for chromosome 14q in neuroblastoma.

Thompson PM, Seifried BA, Kyemba SK, Jensen SJ, Guo C, Maris JM, Brodeur GM, Stram DO, Seeger RC, Gerbing R, Matthay KK, Matise TC, White PS.

Med Pediatr Oncol. 2001 Jan;36(1):28-31.PMID: 11464899 [PubMed - indexed for MEDLINE]Related articles

Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.

Maris JM, Guo C, White PS, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM.

Med Pediatr Oncol. 2001 Jan;36(1):24-7.PMID: 11464895 [PubMed - indexed for MEDLINE]Related articles

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.

Cooper R, Khakoo Y, Matthay KK, Lukens JN, Seeger RC, Stram DO, Gerbing RB, Nakagawa A, Shimada H.

Med Pediatr Oncol. 2001 Jun;36(6):623-9.PMID: 11344493 [PubMed - indexed for MEDLINE]Related articles

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.

Rudnick E, Khakoo Y, Antunes NL, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Matthay KK.

Med Pediatr Oncol. 2001 Jun;36(6):612-22.PMID: 11344492 [PubMed - indexed for MEDLINE]Related articles

Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma.

Reynolds CP, Seeger RC.

J Pediatr Hematol Oncol. 2001 Mar-Apr;23(3):150-2. No abstract available. PMID: 11305717 [PubMed - indexed for MEDLINE]Related articles

Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.

Thompson PM, Maris JM, Hogarty MD, Seeger RC, Reynolds CP, Brodeur GM, White PS.

Cancer Res. 2001 Jan 15;61(2):679-86.PMID: 11212268 [PubMed - indexed for MEDLINE]Related articlesFree article

Residential pesticide exposure and neuroblastoma.

Daniels JL, Olshan AF, Teschke K, Hertz-Picciotto I, Savitz DA, Blatt J, Bondy ML, Neglia JP, Pollock BH, Cohn SL, Look AT, Seeger RC, Castleberry RP.

Epidemiology. 2001 Jan;12(1):20-7.PMID: 11138814 [PubMed - indexed for MEDLINE]Related articles

Phase I study of chimeric human/murine anti-ganglioside G(D2) monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation: a Children's Cancer Group Study.

Ozkaynak MF, Sondel PM, Krailo MD, Gan J, Javorsky B, Reisfeld RA, Matthay KK, Reaman GH, Seeger RC.

J Clin Oncol. 2000 Dec 15;18(24):4077-85.PMID: 11118469 [PubMed - indexed for MEDLINE]Related articles

Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.

Seeger RC, Reynolds CP, Gallego R, Stram DO, Gerbing RB, Matthay KK.

J Clin Oncol. 2000 Dec 15;18(24):4067-76.PMID: 11118468 [PubMed - indexed for MEDLINE]Related articles

Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma.

Choi LM, Kim NW, Zuo JJ, Gerbing R, Stram D, Lukens JN, Matthay KK, Seeger RC, Reynolds CP.

Med Pediatr Oncol. 2000 Dec;35(6):647-50.PMID: 11107138 [PubMed - indexed for MEDLINE]Related articles

Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors.

Goto H, Keshelava N, Matthay KK, Lukens JN, Gerbing RB, Stram DO, Seeger RC, Reynolds CP.

Med Pediatr Oncol. 2000 Dec;35(6):619-22.PMID: 11107131 [PubMed - indexed for MEDLINE]Related articles

Parental smoking and alcohol consumption and risk of neuroblastoma.

Yang Q, Olshan AF, Bondy ML, Shah NR, Pollock BH, Seeger RC, Look AT, Cohn SL.

Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):967-72.PMID: 11008916 [PubMed - indexed for MEDLINE]Related articlesFree article

Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular.

Umehara S, Nakagawa A, Matthay KK, Lukens JN, Seeger RC, Stram DO, Gerbing RB, Shimada H.

Cancer. 2000 Sep 1;89(5):1150-61.PMID: 10964346 [PubMed - indexed for MEDLINE]Related articlesFree article

Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus.

Antunes NL, Khakoo Y, Matthay KK, Seeger RC, Stram DO, Gerstner E, Abrey LE, Dalmau J.

J Pediatr Hematol Oncol. 2000 Jul-Aug;22(4):315-20.PMID: 10959901 [PubMed - indexed for MEDLINE]Related articles

Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.

Maris JM, Weiss MJ, Guo C, Gerbing RB, Stram DO, White PS, Hogarty MD, Sulman EP, Thompson PM, Lukens JN, Matthay KK, Seeger RC, Brodeur GM.

J Clin Oncol. 2000 May;18(9):1888-99.PMID: 10784629 [PubMed - indexed for MEDLINE]Related articles